Showing 7081-7090 of 19322 results for "".
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
https://reachmd.com/programs/cme/duchenne-muscular-dystrophy-differentiating-advances-in-treatment/16654/While glucocorticoids are the current SOC for DMD, long-term exposure comes with debilitating side effects. A safer and more effective option is emerging.Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
https://reachmd.com/programs/cme/mg-therapeutic-selection-and-monitoring-efficacy-matching-mechanisms-to-patients/39030/Examine evolving gMG management, from standard therapies to targeted agents, with an emphasis on pediatric care and assessment of treatment response.Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
https://reachmd.com/programs/cme/moving-forwardwhat-is-on-the-horizon-personalized-therapies-for-patients/35555/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Postbiotics and Microneedling: An Emerging Approach for Acne Relief
https://reachmd.com/programs/clinicians-roundtable/postbiotics-and-microneedling-an-emerging-approach-for-acne-relief/30053/A recent study found that combining probiotics and microneedling shows potential as an alternative acne treatment. Read more about the results.Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12677/What are effective strategies for detecting and diagnosing patients who are at risk of autosomal dominant polycystic kidney disease?Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/valbenazine-for-td-consistent-long-term-efficacy-across-racial-and-ethnic-subgroups-in-kinect-4/37642/Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4What Challenges and Triumphs Do Patients Face While Living With PAH?
https://reachmd.com/programs/cme/what-challenges-and-triumphs-do-patients-face-while-living-with-pah/33242/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
https://reachmd.com/programs/cme/the-latest-patient-centered-recommendations-from-the-7th-world-symposium-on-ph/33236/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
https://reachmd.com/programs/cme/aligning-pah-treatment-plans-with-key-care-goals-and-your-patients-priorities/33238/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
https://reachmd.com/programs/cme/considering-the-promise-of-new-and-emerging-treatments-for-hemophilia-managing-thrombotic-risks/35552/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.